Bacterial Pathogens
|
Infections
|
Reported resistance to
antimicrobials used for treatments
|
Level of resistance
estimation)a
|
Clostridium perfringens type
B and C
|
Enterotoxemia
|
|
+, < 10%
|
Corynebacterium renale
|
Cystitis, pyelonephritis
|
|
-, resistance absent;
|
Escherichia coli (ETEC)
|
Neonatal colibacillosis
|
Ampicillin, gentamicin,
neomycin, sulfas, tetracycline,
trimethoprim-sulfamethoxazole
|
++, 10 - 50%
|
Haemophilus somnus
|
Infectious thromboembolic
meningoencephalitis,
hemophilosis, myocarditis,
pneumonia, polyarthritis
|
|
±, uncertain
|
Leptospira
|
Leptospirosis
|
|
-, resistance absent;
|
Mannheimia haemolytica
|
Pneumonic pasteurellosis
|
Gentamicin, neomycin,
penicillin, sulfas, tetracycline,
trimethoprim-sulfa
|
++, 10 - 50%
|
Moraxella bovis
|
Infectious bovine
keratoconjunctivitis
|
|
++, 10 - 50%
|
Mycobacterium avium ssp
paratuberculosis
|
Paratuberculosis
|
|
-, resistance absent;
|
Pasteurella multocida
|
Pneumonic pasteurellosis
|
Gentamicin, neomycin, penicillin
tetracycline, trimethoprim- sulfa
|
+, < 10%
|
Salmonella
|
Salmonellosis, septicemia
|
Ampicillin, gentamicin,
neomycin, tetracycline,
trimethoprim-sulfa sulfa
|
++, 10 - 50%
|
Staphylococcus aureus
|
Mastitis
|
Erythromycin, penicillin,
pirlimycin, tetracycline
|
+, < 10%
|
| |
Mastitis
|
Erythromycin, penicillin,
spectinomycin, tetracycline
|
+, < 10%
|
Ureaplasma
|
Granular vulvitis
|
|
±, uncertain
|
| |
|
|
|
|